The Quantitative Magnetic Resonance Imaging Unit focuses on the development of MRI techniques and on the analysis of MR data for the assessment of tissue anatomy and function in a clinical setting. One main target is the evaluation of the sensitivity and of the specificity of proton MRI, as well as the MR-based assessment of quantitative physical variables that allow intra-subject and inter-subject comparison.
The MR physics group also deal with technical and clinical aspects of 23Na-MR imaging.
We conduct independent research, support radiological and clinical research, and teach medical and technical students, master students, and Ph.D. students. We provide first-line support for diagnostic scanning and continually advise with regards to a safe operation of our MR scanners.
Medical students, master students, and fellows
Prof. Dr. Daniel Razansky, Institut für Biomedizinische Technik Universität und ETH Zürich
Prof. Dr. Armin Nagel, Professur für metabolische und funktionelle MR-Bildgebung
Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease – European Union Innovative Medicines Initiative.